The rare disease trial landscape stands at a pivotal tipping point. While unprecedented advances in trial design, digital tools, and regulatory flexibility are accelerating innovation like never before, the reality […]

Funding pressures, regulatory shifts, global competition, and relentless layoffs are redefining the pre-commercial biopharma landscape. In this climate, agile, transparent, and people-first leadership is critical to keeping teams engaged, culture […]